Stock SXTP 60 DEGREES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart 60 Degrees Pharmaceuticals, Inc.

Equities

SXTP

US83006G1040

Market Closed - Nasdaq
Other stock markets
 21:00:00 02/07/2024 BST 		5-day change 1st Jan Change
0.2401 USD -6.94% Intraday chart for 60 Degrees Pharmaceuticals, Inc. -14.34% -76.46%
06-27 60 Degrees Pharmaceuticals, Inc. Announces First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center CI
05-30 60 Degrees Pharmaceuticals, Inc. Enters into an Agreement with Tufts Medical Center in Boston to Conduct the First Clinical Trial of Tafenoquine in Treating Human Babesiosis Patients CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
60 DEGREES PHARMACEUTICALS, INC. Stock 60 Degrees Pharmaceuticals, Inc.
 3.15M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 823B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
 352B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 324B
ABBVIE INC. Stock AbbVie Inc.
 301B
  1. Stock Market
  2. Equities
  3. SXTP Stock
  4. Charts 60 Degrees Pharmaceuticals, Inc.
  5. Sector Chart